Deal Details

acquisition of Aptiv Solutions, Inc.

---

Summary

About

ICON plc (“ICON” or the “Company”) (NASDAQ-GS: ICLR) recently acquired Aptiv Solutions, Inc. (“Aptiv Solutions”) from the Halifax Group, SV Life Sciences Advisors and ComVest Investment Partners for $143.5 million.

Aptiv Solutions is a recognized leader in the design and execution of adaptive clinical trials for pharmaceutical and biotech customers. The company also has in-depth experience in the management of medical device trials and its Japanese subsidiary, Niphix, is a full-service, oncology-focused CRO serving both Japanese and international customers. Aptiv Solutions is headquartered in Reston, Virginia.

ICON plc is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. The Company specializes in the strategic development, management and analysis of programs that support clinical development - from compound selection to Phase I-IV clinical studies. ICON has approximately 10,300 employees, operating from 76 locations in 37 countries. ICON plc is headquartered in Dublin, Ireland.

---

For additional information about this transaction, please contact: